E Fund Management (HK)’s CG Oncology CGON Stock Holding History

E Fund Management (HK)’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.2K	Buy	313 +80	+34%	+$5.23K	0.01%	294
2026 Q1	$15.8K	Buy	+233	New	+$13.2K	0.01%	235

Other funds holding CGON

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

E Fund Management (HK)'s CGON Position: Q2 2026 in Review

E Fund Management (HK) increased its CG Oncology (CGON) stake by 34% in Q2 2026, buying an estimated $5.23K and bringing the position to 313 shares worth $22.2K. The position accounts for 0.01% of the portfolio, ranked #294.

E Fund Management (HK) first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

E Fund Management (HK) held 313 shares of CG Oncology worth $22.2K as of Q2 2026.
E Fund Management (HK) bought 80 CG Oncology shares in Q2 2026, an estimated $5.23K.
CG Oncology made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #294 holding.
E Fund Management (HK) first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.